- Tytuł:
- Design and rationale of a single-arm phase II study of neoadjuvant Durvalumab and Gemcitabine associated with Cisplatin or Carboplatin for upper urinary tract urothelial cancer: the iNDUCT trial (NCT04617756)
- Autorzy:
- Źródło:
- World Journal of Urology. 41(12):3413-3420
Czasopismo naukowe